Volume 59, Issue 4, Pages (April 2001)

Slides:

Advertisements

Similar presentations

Table S1. Logistic regression analysis for the variables associated with the degree of change in cTnT between 2 time points (n=89) UnivariateMultivariate.

Advertisements

Echocardiographic Changes in Patients with Stage 3-5 Chronic Kidney Disease and Left Ventricular Diastolic Dysfunction Cardiorenal Med 2014;4:

Vitamin D levels and patient outcome in chronic kidney disease

Volume 68, Issue 3, Pages (September 2005)

Volume 54, Issue 2, Pages (August 1998)

Long-term evolution of cardiomyopathy in dialysis patients

Treatment of Heart Failure With Preserved Ejection Fraction: Have We Been Pursuing the Wrong Paradigm? Gerard O. Oghlakian, MD, Ilke Sipahi, MD, James.

The overdriven glomerulus as a cardiovascular risk factor

Linear and logistic regression analysis

Giovanni Davogustto, MD, Thomas J. Wang, MD, Deepak K. Gupta, MD

Abdominal obesity modifies the risk of hypertriglyceridemia for all-cause and cardiovascular mortality in hemodialysis patients Maurizio Postorino, Carmen.

Confounding: What it is and how to deal with it

Francesca Mallamaci, MD, Giovanni Tripepi, PhD

Sexual Activity and Chronic Heart Failure

The overdriven glomerulus as a cardiovascular risk factor

Volume 86, Issue 3, Pages (September 2014)

Volume 62, Issue 2, Pages (August 2002)

Response to is the reduction in urea distribution volume over time in clinically stable dialysis patients real? S. Andrulli, S. Di Filippo, F. Locatelli

Homocysteine and risk in end-stage renal disease: a matter of context

George A. Kaysen, Burl R. Don

Cross-sectional validity of a modified Edmonton symptom assessment system in dialysis patients: A simple assessment of symptom burden S.N. Davison, G.S.

Treatment of Heart Failure With Preserved Ejection Fraction: Have We Been Pursuing the Wrong Paradigm? Gerard O. Oghlakian, MD, Ilke Sipahi, MD, James.

Volume 67, Issue 6, Pages (June 2005)

N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment Martina Franz, Wolfgang Woloszczuk, Walter.

Volume 77, Issue 2, Pages (January 2010)

G. Tripepi, K.J. Jager, F.W. Dekker, C. Wanner, C. Zoccali

Volume 73, Pages S5-S17 (April 2008)

Volume 74, Issue 9, Pages (November 2008)

Volume 74, Issue 8, Pages (October 2008)

Body size and outcomes on peritoneal dialysis in the United States

Volume 71, Issue 6, Pages (March 2007)

Blood pressure targets in hemodialysis patients

Volume 56, Issue 4, Pages (October 1999)

Volume 67, Issue 5, Pages (May 2005)

Vitamin D levels and patient outcome in chronic kidney disease

Volume 61, Issue 6, Pages (June 2002)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Alternate-day dialysis may be needed for hemodialysis patients

Nephrology Crossword: Peritoneal Dialysis

Volume 61, Issue 4, Pages (April 2002)

Juan M. Lopez-Gomez, Eduardo Verde, Rafael Perez-Garcia

Volume 71, Issue 6, Pages (March 2007)

Long-term evolution of cardiomyopathy in dialysis patients

Volume 53, Issue 4, Pages (April 1998)

Electrocardiographic abnormalities and uremic cardiomyopathy

Laura M. Dember, Erika F. Holmberg, James S. Kaufman

Terry Behrend, Steven B. Miller, M.D Kidney International

A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related.

Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors Carmine Zoccali, Francesca Mallamaci,

Volume 70, Issue 3, Pages (August 2006)

Volume 67, Issue 1, Pages (January 2005)

Volume 63, Issue 2, Pages (February 2003)

Volume 62, Issue 1, Pages (July 2002)

Carmine Zoccali, Francesca Mallamaci Kidney International

Low triiodothyronine and survival in end-stage renal disease

Volume 61, Issue 2, Pages (February 2002)

Volume 80, Issue 10, Pages (November 2011)

Charles A. Herzog Kidney International

Pathophysiology of cardiovascular disease in hemodialysis patients

The Additional Prognostic Value of Left Atrial Volume on the Outcome of Patients After Surgical Ventricular Reconstruction Serenella Castelvecchio, MD,

Volume 68, Issue 2, Pages (August 2005)

Volume 70, Issue 5, Pages (September 2006)

James B. Young, Hans-Hellmut Neumayer, Robert D. Gordon

Predictive value of urinary micro-cholesterol (mCHO) levels in patients with progressive glomerular disease Osamu Hotta, Hisako Sugai, Hiroshi Kitamura,

Volume 70, Issue 10, Pages (November 2006)

The International Pediatric Peritonitis Registry: Starting to walk

Volume 68, Issue 3, Pages (September 2005)

Diagnostic methods 2: receiver operating characteristic (ROC) curves

Sugar-sweetened beverages and chronic disease

Presentation transcript:

Volume 59, Issue 4, Pages 1559-1566 (April 2001) Diagnostic potential of cardiac natriuretic peptides in dialysis patients Francesca Mallamaci, Carmine Zoccali, Giovanni Tripepi, Francesco A. Benedetto, Saverio Parlongo, Alessandro Cataliotti, Sebastiano Cutrupi, Giuseppe Giacone, Ignazio Bellanuova, Benedetta Stancanelli, Lorenzo S. Malatino, on behalf of the CREED INVESTIGATORS Kidney International Volume 59, Issue 4, Pages 1559-1566 (April 2001) DOI: 10.1046/j.1523-1755.2001.0590041559.x Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 1 Relationship between atrial natriuretic peptide (ANP;A) and brain natriuretic peptide (BNP;B) with left ventricular mass indexed to height (LVMI). Data are expressed as the Pearson product moment correlation coefficient and the relative P value. The corresponding multivariable models are reported in the insets. ***P < 0.0001; **P < 0.01; *P < 0.05. Kidney International 2001 59, 1559-1566DOI: (10.1046/j.1523-1755.2001.0590041559.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 2 Relationship between ANP and BNP with ejection fraction (EF). Data are expressed as the Pearson product moment correlation coefficient and the relative P value. The corresponding multivariable models are reported in the insets. ***P < 0.0001; **P < 0.01; *P < 0.05. Kidney International 2001 59, 1559-1566DOI: (10.1046/j.1523-1755.2001.0590041559.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 3 Receiver operating characteristic (ROC) curves for natriuretic peptide concentrations in predicting abnormal LV mass and EF (Methods section). (A) Left ventricular hypertrophy; (B) left ventricular dysfunction. Kidney International 2001 59, 1559-1566DOI: (10.1046/j.1523-1755.2001.0590041559.x) Copyright © 2001 International Society of Nephrology Terms and Conditions